RECOMBINANT HUMANISED IgG1 KAPPA ANTI-ONCOSTATIN M MONOCLONAL ANTIBODY GSK2330811

Scleroderma, Systemic

GlaxoSmithKlinemonoclonal_antibodyPhase 2Dormant

57/ 100

Provisional rating · Methodology v0.2

Rating breakdown

25 Active assets in the Scleroderma, Systemic cohort.

Asset / Sponsor	Phase	Rating
Cyclophosphamide Royal Brompton & Harefield NHS Foundation Trust	Phase 2/3	BB
Iloprost National Center for Research Resources (NCRR)	Phase 3	BB
Bosentan Actelion	Phase 3	B
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Royal Brompton & Harefield NHS Foundation Trust	Phase 2/3	B
Anti-Thymoglobulin, Rabbit Fred Hutchinson Cancer Center	Phase 2	B

View all 41 →

Order a full diligence report on this asset.

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.